HIPRA develops vaccines, diagnostic products, medical devices and traceability services for animal and human health, applying recent scientific advances across research, manufacturing, diagnostics and commercial operations. The company also provides contract development and manufacturing services through HIPRA Biotech Services (CDMO), working to scientific, regulatory and quality standards.
The technical scope of its work spans vaccine development, diagnostics, biotechnology and traceability. HIPRA runs 11 diagnostic centers and six production plants, in Spain and Brazil, and reinvests approximately 15% of annual turnover in research and development. It has a commercial presence in more than 40 countries and a distribution network reaching over 100.
Roles are available for scientists, engineers, regulatory specialists and commercial professionals, with multidisciplinary teams working across research, manufacturing, diagnostics and commercial operations. The company describes an internal talent development programme, continuous learning and a feedback culture, and offers responsibility for projects with direct impact on animal and human health, alongside long-term career opportunities and attention to work-life balance.
